STAT3 in Prostate Cancer: Whom Should We Treat and When?

被引：7
|
作者：
Culig, Zoran [1 ]
机构：
[1] Med Univ Innsbruck, Dept Urol, Expt Urol, Anichstr 35, A-6020 Innsbruck, Austria
来源：
EUROPEAN UROLOGY | 2017年 / 71卷 / 03期
关键词：
INTERLEUKIN-6; CELLS; ANTIBODY; GROWTH; MICE;
D O I：
10.1016/j.eururo.2016.06.034
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：317 / 318
页数：2
相关论文
共 50 条
  • [41] Cardiovascular risk factors: when should we treat?
    Tonkin, AR
    Lim, SS
    Schirmer, H
    MEDICAL JOURNAL OF AUSTRALIA, 2003, 178 (03) : 101 - 102
  • [42] When should we use rituximab to treat RA?
    Yusuf Yazici
    Nature Reviews Rheumatology, 2011, 7 : 379 - 380
  • [43] Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells
    Mora, LB
    Buettner, R
    Seigne, J
    Diaz, J
    Ahmad, N
    Garcia, R
    Bowman, T
    Falcone, R
    Fairclough, R
    Cantor, A
    Muro-Cacho, C
    Livingston, S
    Karras, J
    Pow-Sang, J
    Jove, R
    CANCER RESEARCH, 2002, 62 (22) : 6659 - 6666
  • [44] STAT3 regulated ARF expression suppresses prostate cancer metastasis
    Jan Pencik
    Michaela Schlederer
    Wolfgang Gruber
    Christine Unger
    Steven M. Walker
    Athena Chalaris
    Isabelle J. Marié
    Melanie R. Hassler
    Tahereh Javaheri
    Osman Aksoy
    Jaine K. Blayney
    Nicole Prutsch
    Anna Skucha
    Merima Herac
    Oliver H. Krämer
    Peter Mazal
    Florian Grebien
    Gerda Egger
    Valeria Poli
    Wolfgang Mikulits
    Robert Eferl
    Harald Esterbauer
    Richard Kennedy
    Falko Fend
    Marcus Scharpf
    Martin Braun
    Sven Perner
    David E. Levy
    Tim Malcolm
    Suzanne D. Turner
    Andrea Haitel
    Martin Susani
    Ali Moazzami
    Stefan Rose-John
    Fritz Aberger
    Olaf Merkel
    Richard Moriggl
    Zoran Culig
    Helmut Dolznig
    Lukas Kenner
    Nature Communications, 6
  • [45] Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells
    Gong, Aiyu
    He, Meilan
    Vanaja, Donkena Krishna
    Yin, Ping
    Karnes, R. Jeffrey
    Young, Charles Y. F.
    MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 (07) : 878 - 886
  • [46] Transcription factor Stat3 promotes metastatic progression of prostate cancer
    Gu, Lei
    Abdulghani, Junaid
    Dagvadorj, Ayush
    Lutz, Jacqueline
    Bonuccelli, Gloria
    Lisanti, Michael P.
    Zellweger, Tobias
    Alanen, Kalle
    Mirtti, Tuomas
    Visakorpi, Tapio
    Bubendorf, Lukas
    Nevalainen, Marja T.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 392 - 392
  • [47] Hippo pathway monomerizes STAT3 to regulate prostate cancer growth
    Tang, Qingfeng
    Fang, Jing
    Lai, Weiqi
    Hu, Yu
    Liu, Chengwan
    Hu, Xiaobo
    Song, Caiyong
    Cheng, Tianmu
    Liu, Rui
    Huang, Xiaoke
    CANCER SCIENCE, 2022, 113 (08) : 2753 - 2762
  • [48] STAT3 regulated ARF expression suppresses prostate cancer metastasis
    Pencik, Jan
    Schlederer, Michaela
    Gruber, Wolfgang
    Unger, Christine
    Walker, Steven M.
    Chalaris, Athena
    Marie, Isabelle J.
    Hassler, Melanie R.
    Javaheri, Tahereh
    Aksoy, Osman
    Blayney, Jaine K.
    Prutsch, Nicole
    Skucha, Anna
    Herac, Merima
    Kraemer, Oliver H.
    Mazal, Peter
    Grebien, Florian
    Egger, Gerda
    Poli, Valeria
    Mikulits, Wolfgang
    Eferl, Robert
    Esterbauer, Harald
    Kennedy, Richard
    Fend, Falko
    Scharpf, Marcus
    Braun, Martin
    Perner, Sven
    Levy, David E.
    Malcolm, Tim
    Turner, Suzanne D.
    Haitel, Andrea
    Susani, Martin
    Moazzami, Ali
    Rose-John, Stefan
    Aberger, Fritz
    Merkel, Olaf
    Moriggl, Richard
    Culig, Zoran
    Dolznig, Helmut
    Kenner, Lukas
    NATURE COMMUNICATIONS, 2015, 6
  • [49] HOW FAR SHOULD WE INVESTIGATE AND TREAT PROSTATE-CANCER - A LAWYERS PERSPECTIVE
    GERBER, P
    MEDICAL JOURNAL OF AUSTRALIA, 1994, 160 (08) : 523 - 524
  • [50] Aged patients with metastatic castration resistant prostate cancer: Should we treat with chemotherapy?
    Angel Climent, Miguel
    Dolores Torregrosa, Ma
    Vazquez, Sergio
    Girones, Regina
    Angel Arranz, Jose
    CANCER TREATMENT REVIEWS, 2017, 55 : 173 - 180
12345